Unfortunately, the sad reality is that there is a paucity of analysts in Australia with an in depth understanding of the biotech industry - I don't listen to most of them.
On the bright side, this increases the potential for market inefficiencies and opportunities for the savvy investor.
Ann: 1H24 Trading Result (unaudited), page-115
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.39 |
Change
0.000(0.00%) |
Mkt cap ! $1.650B | |||
| Open | High | Low | Value | Volume |
| $2.40 | $2.41 | $2.37 | $1.760M | 736.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23241 | $2.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.39 | 381 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |